Detalhe da pesquisa
1.
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.
Cancer Immunol Immunother
; 59(1): 161-71, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19621224
2.
Formulation and characterization of a ten-peptide single-vial vaccine, EP-2101, designed to induce cytotoxic T-lymphocyte responses for cancer immunotherapy.
Hum Vaccin
; 4(3): 210-8, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18382135
3.
A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102.
Clin Cancer Res
; 16(3): 825-34, 2010 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20103660
4.
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.
Cancer Res
; 68(12): 4893-901, 2008 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18559537
5.
A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery.
J Immunol
; 168(12): 6189-98, 2002 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12055232